The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma
<p>Abstract</p> <p>Background</p> <p>The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described.</p> <p>Case presentation</p> <p>Herein we present two cases where fulv...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-12-01
|
| Series: | World Journal of Surgical Oncology |
| Online Access: | http://www.wjso.com/content/6/1/128 |
| Summary: | <p>Abstract</p> <p>Background</p> <p>The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described.</p> <p>Case presentation</p> <p>Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast cancer has the opportunity to provide a means to initiate treatment in those patients who present with varying degrees of intestinal obstruction.</p> <p>Conclusion</p> <p>Fulvestrant may obviate the use of chemotherapy while achieving sustained clinical benefit with less toxicity, in appropriately selected patients.</p> |
|---|---|
| ISSN: | 1477-7819 |